局部进展期胃癌患者新辅助化疗后围手术期的临床观察

饶芸; 骆群; 徐萍; 刘媛; 王智

doi:10.16016/j.1000-5404.201805212

您当前的位置：

首页 >

文章列表页 >

局部进展期胃癌患者新辅助化疗后围手术期的临床观察

临床医学 | 更新时间：2026-01-09

- 局部进展期胃癌患者新辅助化疗后围手术期的临床观察
- Perioperative characteristics of patients with locally advanced gastric cancer receiving preoperative neoadjuvant chemotherapy
- 第三军医大学学报 2018年40卷第22期页码：2098-2101
- 作者机构：
  
  400038 陆军军医大学(第三军医大学)第一附属医院全军普通外科中心，微创胃肠外科中心
- 作者简介：
  
  [ 饶芸, E-mail: maggie_ry@aliyun.com RAO Yun, E-mail: maggie_ry@aliyun.com
- 基金信息：
  
  重庆市社会事业与民生保障科技创新专项(CSTC2017shmaA1003)
- DOI：10.16016/j.1000-5404.201805212
  中图分类号： R473.6;R730.53;R735.2
- 收稿：2018-06-01，
  
  修回：2018-07-12，
  
  纸质出版：2018-11-30
- 稿件说明：
移动端阅览
饶芸, 骆群, 徐萍, 等. 局部进展期胃癌患者新辅助化疗后围手术期的临床观察[J]. 第三军医大学学报, 2018,40(22):2098-2101.

Yun RAO, Qun LUO, Ping XU, et al. Perioperative characteristics of patients with locally advanced gastric cancer receiving preoperative neoadjuvant chemotherapy[J]. Journal of Third Military Medical University, 2018, 40(22): 2098-2101.
饶芸, 骆群, 徐萍, 等. 局部进展期胃癌患者新辅助化疗后围手术期的临床观察[J]. 第三军医大学学报, 2018,40(22):2098-2101. DOI： 10.16016/j.1000-5404.201805212.

Yun RAO, Qun LUO, Ping XU, et al. Perioperative characteristics of patients with locally advanced gastric cancer receiving preoperative neoadjuvant chemotherapy[J]. Journal of Third Military Medical University, 2018, 40(22): 2098-2101. DOI： 10.16016/j.1000-5404.201805212.

摘要

目的

比较腹腔镜根治性手术术前接受与未接受新辅助化疗的局部进展期胃癌患者的临床资料，探讨接受新辅助化疗后腹腔镜根治性手术患者的临床观察重点及护理要点。

方法

收集2016-2017年本院接受新辅助化疗后手术的局部进展期胃癌患者(新辅助化疗后手术组)31例及直接接受根治性手术的局部进展期胃癌患者(直接手术组)48例，比较两组年龄、术前体质量指数(BMI)、术前血红蛋白(Hb)、术前白细胞计数(WBC)、术前白蛋白(Alb)、围手术期平均收缩压(SBP)、术中出血量、手术时间、术后第1天(D1)尿量、术后第1天(D1)腹腔引流量、术后平均住院时间等临床资料，分析两组间差异与近期疗效的相关性，总结接受新辅助化疗后手术患者的围手术期特点。

结果

本研究纳入79例局部进展期胃癌患者，新辅助化疗后手术组平均年龄59.06岁，直接手术组平均年龄57.96岁，两组比较差异无统计学意义。新辅助化疗后手术组术前BMI[(22.23±1.85)

(23.77± 1.57) kg/m

，

0.01

]

、Hb水平[(113.19±23.24)

(126.10±27.06) g/L，

=0.027

]

及WBC水平[(4.79±1.38)×10

(5.87±2.17)×10

/L，

=0.008

]

均较直接手术组低，而术后第1天腹腔引流量[(319.58±249.90)

(181.29±137.16) mL，

=0.002

]

较直接手术组更多，术后住院时间[(12.45±6.12)

(9.35±2.49) d，

=0.002

]

较直接手术组更长，差异均有统计学意义。

结论

接受新辅助化疗的患者较直接手术的患者营养状况、手术耐受性更差。早期营养状况改善、加强术后循环水平监测及处理等措施，可提高此类患者围手术期安全，利于术后康复。

Abstract

Objective

To compare the clinical and perioperative data of patients with locally advanced gastric cancer patients undergoing laparoscopic radical surgery with and without preoperative neoadjuvant chemotherapy and analyze the clinical management and nursing strategies for these patients.

Methods

We retrospectively analyzed the clinical data of 79 with locally advanced gastric cancer undergoing radical operation in our hospital between 2016 and 2017. Of these patients

31 received neoadjuvant chemotherapy prior to laparoscopic radical surgery and 48 directly underwent the surgery without preoperative neoadjuvant chemotherapy. The perioperative characteristics

surgical data and outcomes of the patients were analyzed.

Results

The patients receiving preoperative neoadjuvant chemotherapy and those without neoadjuvant chemotherapy were matched for age at surgery (59.06±11.19

57.96±9.22 years

0.05). Compared with those without neoadjuvant chemotherapy

the patients receiving neoadjuvant chemotherapy before laparoscopic radical surgery had a significantly lower mean preoperative BMI (22.23±1.85

23.77±1.57 kg/m

0.001)

a lower preoperative hemoglobin level (113.19±23.24

126.10±27.06 g/L

=0.027)

a lower preoperative white blood cell count [(4.79±1.38)×10

(5.87±2.17)×10

=0.008

]

a greater volume of abdominal drainage on the first day after the operation (319.58±249.90

181.29±137.16 mL

=0.002)

and a longer postoperative hospital stay (12.45±6.12

9.35±2.49 d

=0.002).

Conclusion

Compared with those directly undergoing radical operation for locally advanced gastric cancer

the patients receiving preoperative neoadjuvant chemotherapy have poorer preoperative conditions in terms of nutrition

hemoglobin level

white blood cell count

and tolerance of surgery. Preoperative nutrition therapy

monitoring and timely interventions of blood perfusion level can help to improve the perioperative safety and promote postoperative recovery of these patients.

关键词

Keywords

references

OKABE H, HATA H, UEDA S, et al . A phase Ⅱ study of neoadjuvant chemotherapy with S-1 and cisplatin for stage Ⅲ gastric cancer: KUGC03[J ] . J Surg Oncol, 2016, 113(1): 36-41. DOI:10.1002/jso.24096.

OKI E, EMI Y, KUSUMOTO T, et al . Phase Ⅱ study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage Ⅲ resectable gastric cancer[J ] . Ann Surg Oncol, 2014, 21(7): 2340-2346. DOI: 10.1245/s10434-014-3594-9.

肖凤, 刘彬, 高红英, 等.进展期胃癌新辅助化疗疗效的Meta分析[J].重庆医学, 2012, 41(25): 2591-2594.

XIAO F, LIU B, GAO H Y, et al . A Meta analysis on curative effects of neoadjuvant chemotherapy for treating advanced gastric cancer[J ] . Chongqing Med, 2012, 41(25): 2591-2594.

BIFFI R, FAZIO N, LUCA F, et al . Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer[J ] . World J Gastroenterol, 2010, 16(7): 868-874.

LI Z, SHAN F, WANG Y, et al . Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: a meta-analysis[J ] . PLoS ONE, 2018, 13(1): e0189294. DOI: 10.1371/journal.pone.0189294.

李子禹, 陕飞, 王胤奎.新辅助化疗后的胃癌腔镜手术研究[J].中华腔镜外科杂志(电子版), 2017, 10(4): 200-202.

LI Z Y, SHAN F, WANG Y K. Endoscopic surgery for gastric cancer after neoadjuvant chemotherapy[J]. Chin J Laparo Surg (Electr Ed), 2017, 10(4): 200-202.

[National Comprehensive Cancer Network. Gastric Cancer, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology[EB/OL ] . (2018-03-16)[2018-05-20 ] . https://www.nccn.org/professionals/physician-gls/pdf/gastric.pdf https://www.nccn.org/professionals/physician-gls/pdf/gastric.pdf .

TU R H, LIN J X, ZHENG C H, et al . Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer[J ] . Eur J Surg Oncol, 2017, 43(2): 485-492. DOI:10.1016/j.ejso.2016.11.022.

YAMANAKA H, NISHI M, KANEMAKI T, et al . Preoperative nutritional assessment to predict postoperative complication in gastric cancer patients[J ] . JPEN J Parenter Enteral Nutr, 1989, 13(3): 286-291. DOI:10.1177/0148607189013003286.

MUELLER T C, SCHIRREN R, KEHL V, et al . Parenteral nutrition during neoadjuvant chemotherapy for patients with non-metastatic gastric or esophago-gastric cancer to reduce postoperative morbidity (PERCOG): study protocol for a randomized controlled trial[J ] . Trials, 2017, 18(1): 621. DOI: 10.1186/ s13063-017-2388-3.

沈策, 刘皓, 左强, 等.短期化疗对兔腹主动脉顺应性的影响[J].第一军医大学学报, 2005, 25(11): 1443-1445.

SHEN C, LIU H, ZUO Q, et al . The effect of short-term chemotherapy on the compliance of abdominal aorta in rabbits[J ] . J First Mili Med Univ, 2005, 25(11): 1443-1445.

EOM B W, KIM S, KIM J Y, et al . Survival benefit of perioperative chemotherapy in patients with locally advanced gastric cancer: a propensity score matched analysis[J ] . J Gastric Cancer, 2018, 18(1): 69-81. DOI: 10.5230/jgc.2018.18.e9.

TOBAR E, ABEDRAPO M A, GODOY J A, et al . Impact of hypotension and global hypoperfusion in postoperative delirium: a pilot study in older adults undergoing open colon surgery[J ] . Rev Bras Anestesiol, 2018, 68(2): 135-141. DOI:10.1016/j.bjan.2017.10.002.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

单孔与传统腹腔镜下行宫颈癌根治手术患者围手术期对比研究

1例巨大腹壁间质瘤切除围手术期护理体会

达芬奇机器人系统全胃切除术的围手术期护理

21例腹腔镜肝切除术的围手术期护理

腹腔镜辅助下胃癌根治术患者的围手术期护理